AMS

2 articles

Business Watch: Fuller to Buy Wound-Care Company AMS; Novartis, Antares Ink Agreement for Cancer Small Molecules

Fuller plans to acquire wound-care company AMS, while Novartis and Antares agree on cancer small molecules; the report notes hardware stores remain key outlets for chemical products despite retail con

cen · 2026-06-30 00:00

H.B. Fuller’s Acquisition of AMS Faces Renewed Criticism from Activist

H.B. Fuller proposed a £715 million acquisition of wound-care supplier AMS, facing criticism from activist investor Ancora Holdings who urged deleveraging. The deal aims to expand market reach and ach

chemweek · 2026-06-26 01:05